AI Smart Rings for Clinical Trials and Healthcare Research

Why Smart Rings Are Gaining Ground in Clinical Research

The clinical research community has spent the last several years warming up to consumer wearables. And smart rings, in particular, have emerged as a serious contender for longitudinal health studies.

A 2025 systematic review published in Biomimetics analyzed 107 studies involving smart rings in clinical medicine, covering roughly 100,000 participants. The research split almost evenly between sleep-related applications and non-sleep applications like cardiovascular monitoring, stress tracking, and reproductive health. The Oura Ring appeared in 72% of those studies — a clear sign that the device has crossed from consumer novelty into legitimate research tool.

The accuracy numbers back this up. Smart rings have demonstrated heart rate correlation values of r² = 0.996 and HRV correlation of r² = 0.980 against clinical-grade instruments. Sleep detection sensitivity lands between 93–96%. These aren't approximations. They're numbers that hold up under peer review.

And the form factor matters. Unlike wrist-worn devices that can interfere with daily routines or feel clinical, a ring disappears into a participant's life. That translates directly into higher compliance rates. One study on digital cognitive behavioral therapy for insomnia found that participants adhered to smart ring wear at significantly higher rates than they did to manual sleep diaries — 52.5% vs. lower diary completion rates — simply because the ring required zero effort after putting it on.

The Procurement Problem Nobody Talks About

Here's where things get complicated for research teams.

You've designed your study protocol. You know you want to collect continuous HRV, sleep staging, and skin temperature data from a cohort of 50, 100, or 500 participants. You've selected your device. Now you need to actually get those devices.

The logistics of wearable procurement in clinical trials are surprisingly painful. A survey of clinical research stakeholders found that over 69% cited expensive implementation, device choice, and logistical considerations as the primary disadvantages of incorporating wearables. Another 71% pointed to operational challenges as their top concern.

For smart rings specifically, the problems multiply:

• Sizing complexity. Unlike a wristband that adjusts, rings come in fixed sizes. The Oura Ring ships in sizes 6–13. Samsung Galaxy Ring covers a similar range. Every participant needs a sizing kit before you can even order their device. That's a pre-study logistics layer that adds weeks.
• Capital outlay. At $299–$399 per device, outfitting a 200-person cohort means $60,000–$80,000 in hardware before a single data point is collected. If you're comparing two ring platforms (say, Oura vs. Samsung), double it.
• Device management. Participants drop out. Devices break. Studies end. Now you're sitting on inventory you may never use again — or scrambling to find participants to replace a broken unit mid-study.
• Multi-device comparison. Some study designs require testing multiple wearable platforms against each other. Buying retail inventory of three different rings for a single study is cost-prohibitive for most labs.

These aren't theoretical problems. They're the reason many research teams default to whatever device is easiest to procure (historically Fitbit, via its dropship API) rather than whatever device is best for their study question.

What Researchers Actually Need From a Smart Ring

Different study designs call for different capabilities. Here's a breakdown of what the major smart ring platforms offer and where each one fits in a research context.

Oura Ring Gen 4

Oura is the incumbent in clinical research for good reason. Its sensor suite includes green and infrared LEDs for heart rate and HRV, red and infrared LEDs for SpO2, a negative temperature coefficient sensor for skin temperature, and a 3D accelerometer for movement. The platform has been validated in peer-reviewed studies across sleep staging, nocturnal heart rate, and heart rate variability — with both Generation 3 and Generation 4 devices showing nearly identical performance metrics.

An independent study funded by the Air Force Research Laboratory found Oura Ring Gen 4 achieved the highest accuracy for both resting heart rate (CCC = 0.98, MAPE = 1.94%) and HRV (CCC = 0.99, MAPE = 5.96%) compared to Garmin, Polar, and WHOOP devices. For research teams focused on cardiovascular or sleep endpoints, Oura is the most validated option available.

The trade-off: Oura requires a $5.99/month membership for full app access. In a research context, that's an additional recurring cost per participant.

Rent with Techloop for $42/month — includes the device and lets your team swap to a different ring if your protocol changes.

Samsung Galaxy Ring

Samsung's entry into the smart ring market brings ecosystem advantages that matter for certain study designs. The Galaxy Ring integrates deeply with Samsung Health, tracks sleep, heart rate, skin temperature, and SpO2, and requires no subscription. For Android-heavy participant populations or studies already embedded in Samsung's health ecosystem, it's a clean fit.

The Galaxy Ring 2, expected later in 2026, may feature solid-state battery technology that could double battery life — a meaningful improvement for longitudinal studies where charging compliance is an issue.

Rent with Techloop for $42/month — no subscription fees, no long-term hardware commitment.

Ultrahuman Ring Air

Ultrahuman has positioned itself as the health-stack alternative. Its Ring Air tracks the core biometrics (heart rate, HRV, skin temperature, SpO2, movement) and feeds data into a broader platform that includes metabolic health features and, through its acquisition of viO HealthTech, clinical-grade cycle and ovulation tracking.

For reproductive health research and women's health cohort studies, Ultrahuman's combination of ring data and cycle algorithms is worth evaluating. The OvuSense-derived algorithms claim over 90% accuracy for ovulation confirmation, including for participants with irregular cycles.

Rent with Techloop for $42/month — try it alongside Oura or Samsung to evaluate fit for your protocol.

How Techloop Works for Research Teams

Techloop wasn't built specifically for clinical trials. It's a consumer rental platform for AI wearables. But the model solves several problems that research teams face — often more efficiently than traditional procurement channels.

Here's the practical breakdown:

One subscription covers the device. Instead of purchasing 100 Oura Rings at $349 each ($34,900), your lab rents them at $42/month per device. For a 6-month study, that's $25,200 — with no residual inventory to manage afterward. If participants purchase the devices post-study, rental payments apply as credit toward the retail price.

Sizing is handled. Techloop includes sizing kits as part of the rental process. Participants get sized, devices ship in the correct fit, and replacements are straightforward if someone's between sizes.

Swaps are built in. If your study design calls for comparing Oura Ring and Samsung Galaxy Ring across the same cohort, participants can swap devices mid-study using Techloop's standard swap process. No new purchase orders. No surplus inventory.

Returns are simple. When the study ends, participants return devices in prepaid packaging. No asset tracking spreadsheets. No e-waste pile in the lab closet.

Multiple devices, one account. Running a multi-arm study with three different ring platforms? Manage all devices under a single Techloop account with one monthly invoice.

Study Design Scenarios

To make this concrete, here are three research use cases where Techloop's rental model maps cleanly to common study designs.

Scenario 1: Sleep and Recovery Cohort Study

Design: 60 participants, 90-day observation period, primary endpoints are sleep efficiency and HRV trends.

Device: Oura Ring Gen 4 (strongest sleep validation data).

Traditional cost: 60 × $349 = $20,940 in hardware + $5.99/mo membership × 60 × 3 months = $1,078. Total: ~$22,000, plus you own 60 rings you may not need again.

Techloop cost: 60 × $42/mo × 3 months = $7,560. Devices returned at study end. If some participants want to keep their ring, their rental payments count toward purchase.

Scenario 2: Cross-Platform Validation Study

Design: 30 participants wear both Oura Ring and Samsung Galaxy Ring simultaneously for 30 days. Primary endpoint is inter-device agreement on HRV and sleep staging.

Device: Oura Ring Gen 4 + Samsung Galaxy Ring (one on each hand).

Traditional cost: 30 × $349 (Oura) + 30 × $399 (Samsung) = $22,440. Plus sizing kits for both platforms.

Techloop cost: 60 devices × $42/mo × 1 month = $2,520. Return everything after 30 days. No leftover inventory.

Scenario 3: Women's Health Longitudinal Study

Design: 100 participants tracked over 12 months for cycle regularity, ovulation detection, and sleep-hormone correlations.

Device: Ultrahuman Ring Air (ovulation tracking algorithms) or Oura Ring (established cycle tracking).

Traditional cost: 100 × $349 = $34,900. High risk of participant dropout over 12 months leaving unused devices.

Techloop cost: Start with 100 devices at $42/mo. As participants drop out, scale down. Devices returned by dropouts go back into the pool. You only pay for active participants. Month 12 cost reflects actual retention, not original enrollment.

The Data Landscape: What Smart Rings Can (and Can't) Measure

Smart rings are not medical devices. They're consumer wearables with increasingly clinical-grade accuracy in specific domains. Research teams should understand both the strengths and the boundaries.

Strong clinical evidence exists for:

• Nocturnal heart rate and resting heart rate (r² = 0.996 against ECG in peer-reviewed studies)
• Heart rate variability, especially RMSSD (r² = 0.980)
• Sleep/wake detection (93–96% sensitivity)
• Sleep staging (light, deep, REM) with moderate to high accuracy depending on the algorithm version
• Skin temperature trends (useful for fever detection, cycle tracking, circadian rhythm research)

Emerging but less validated:

• Blood oxygen (SpO2) during sleep — useful for screening, but not diagnostic
• Stress tracking via cumulative HRV analysis
• Blood pressure estimation (investigational in some platforms)
• Metabolic health correlations via temperature and HRV patterns

Not currently measurable:

• Blood glucose (no ring has this yet, despite market hype)
• ECG-grade cardiac rhythm analysis (some rings are approaching this, but regulatory clearance is limited)
• Continuous daytime blood pressure

For study protocols that rely on heart rate, HRV, sleep, and temperature endpoints, smart rings offer a validated, participant-friendly alternative to chest straps, wrist-based actigraphy, and in-lab polysomnography — at a fraction of the cost and participant burden.

Compliance and Participant Experience

The single biggest threat to any wearable-based study is non-compliance. If participants don't wear the device, you don't have data.

Smart rings have a structural advantage here. They're smaller and lighter than smartwatches. They don't have screens that distract or notification lights that annoy. They charge quickly (most models fully charge in 60–90 minutes) and last 4–7 days on a single charge. Participants often forget they're wearing one — which is exactly what you want.

Research has shown that wearable adherence improves when participants feel they're using a consumer product rather than a medical instrument. Smart rings look like jewelry. They don't signal "I'm in a study" to the outside world. That psychological comfort translates into longer wear times and more complete datasets.

Techloop adds another layer here: because participants are using a rental service rather than receiving a "study device," the experience feels less clinical. They have their own account, their own app, and their own data. If a participant decides to keep the ring after the study, they can purchase it with their rental payments applied as credit. That sense of personal ownership — even during the study — tends to boost engagement.

Getting Started

If you're a researcher, lab manager, or study coordinator evaluating smart rings for your next trial or cohort study, here's the quickest path:

1. Define your endpoints. What biometric data does your protocol require? Heart rate, HRV, sleep staging, temperature, SpO2? This determines which ring platform fits best.
2. Estimate your cohort size and duration. Techloop's pricing starts at $42/month per device (with multi-device discounts at $75/month for two and $100/month for three). Multiply by participants and months to get your total device budget.
3. Contact Techloop. Reach out at hello@trytechloop.com to discuss volume accounts, sizing logistics, and multi-device setups. We can walk you through the process for research-specific deployments.
4. Deploy and collect. Participants receive new devices, use them in their daily lives, and generate continuous biometric data. When the study ends, devices come back.

No capital expenditure. No surplus inventory. No procurement headaches.

The Bigger Picture

The wearable technology market is projected to reach $500 billion by 2036. Smart rings are one of the fastest-growing segments within that market, with 12% U.S. household penetration as of 2025 — roughly 15 million households and 26 million installed devices.

For clinical research, this growth means more validated devices, better algorithms, and larger normative datasets to compare against. It also means more options — and more confusion about which device to choose.

Techloop cuts through that confusion by removing the biggest barrier: commitment. You don't have to bet your study budget on one device. You can rent, test, compare, and scale — on a timeline that matches your research, not a procurement cycle.

Smart rings are ready for clinical research. The question is whether your procurement process is ready for smart rings.

Explore devices on Techloop →